Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide

NCT05023941 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
252
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ji Xunming,MD,PhD